Pyros Pharmaceuticals

Pyros Pharmaceuticals company information, Employees & Contact Information

Pyros Pharmaceuticals is a specialty pharmaceutical company focused on developing medicines for rare pediatric diseases and underserved patient populations. We explore a broad range of therapeutic areas that have technically challenging drug delivery mechanisms or other niche applications. Our goal is to provide high-quality, affordable and accessible alternatives for patients that need them the most.

Company Details

Employees
15
Founded
-
Address
2001 Us-46,
Phone
201-743-9468
Email
bd****@****ma.com.
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Parsippany, New Jersey
Looking for a particular Pyros Pharmaceuticals employee's phone or email?

Pyros Pharmaceuticals Questions

News

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution) - Business Wire

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution) Business Wire

Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals - PR Newswire

Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals PR Newswire

Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available - Business Wire

Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available Business Wire

Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™ (vigabatrin) as the First and Only Ready-to-Use Vigabatrin Oral Solution - Business Wire

Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™ (vigabatrin) as the First and Only Ready-to-Use Vigabatrin Oral Solution Business Wire

Pyros Pharmaceuticals Announces VIGAFYDE™ (vigabatrin), the First and Only Ready-to-Use Vigabatrin Oral Solution, is Now Available - Business Wire

Pyros Pharmaceuticals Announces VIGAFYDE™ (vigabatrin), the First and Only Ready-to-Use Vigabatrin Oral Solution, is Now Available Business Wire

Top Pyros Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant